DASH SARS-CoV-2 & Flu A/B Test

About Nuclein

Nuclein is a private diagnostics company commercializing a rapid, point-of-care PCR system called DASH. The platform distinguishes itself by offering lab-quality molecular results in 15 minutes with minimal hands-on time, room-temperature stable cartridges, and a small, affordable instrument footprint suitable for decentralized care settings. With an initial FDA-cleared product for COVID-19 and flu, the company is positioned to expand its test menu into other infectious disease areas, targeting the growing demand for fast, accurate diagnostics at the point of care.

Therapeutic Areas